What did Fisher & Paykel Healthcare Corporation Limited announce?
Fisher & Paykel Healthcare Corporation Limited (NZX: FPH) filed “Capital Change Notice - Issue of Employee Share Rights” with NZX on 9 September 2026, as a capital change announcement.
- When was it filed?
- 9 September 2026
- Where is the original?
- NZX announcement
Capital Change Notice - Issue of Employee Share Rights
Capital Change Notice
9 September 2026
Issue of Employee Share Rights
This notice is given under NZX Listing Rule 3.13.1 and relates to unlisted Employee Share Rights to acquire
ordinary shares in the Company (‘ESRs’) issued under the Fisher & Paykel Healthcare Employee Share
Rights Plan (‘Employee Share Rights Plan’), the Sub-Plan for France (‘Sub-Plan for France’) and the Fisher
& Paykel Healthcare Employee Share Rights Plan – North America (‘North America Plan’).
Section 1: Issuer information
Name of issuer
Fisher & Paykel Healthcare
Corporation Limited
NZX ticker code FPH
Class of financial product Unlisted ESRs to acquire ordinary
shares in the Company issued
under the Employee Share Rights
Plan, the Sub-Plan for France and
the North America Plan.
ISIN (If unknown, check on NZX website) NZFAPE0001S2
Currency NZD
Section 2: Capital change details
Number issued/acquired/redeemed 299,018
Nominal value (if any) Not applicable
Issue/acquisition/redemption price per security
No amount is payable for the grant
of ESRs. One ESR will convert
into one ordinary share at no cost
after three years, provided the
recipient remains an employee of
the Company.
Nature of the payment (for example, cash or other consideration) Not applicable
Amount paid up (if not in full) Not applicable
Percentage of total class of Financial Products
issued/acquired/redeemed/ (calculated on the number of Financial
Products of the Class, excluding any Treasury Stock, in existence)
1
299,018 ESRs to acquire ordinary
shares representing approximately
0.0508% of the ordinary shares on
issue.
For an issue of Convertible Financial Products or Options, the
principal terms of Conversion (for example the Conversion price and
Conversion date and the ranking of the Financial Product in relation
to other Classes of Financial Product) or the Option (for example,
the exercise price and exercise date)
Not applicable
Reason for issue/acquisition/redemption and specific authority for
issue/acquisition/redemption/ (the reason for change must be
identified here)
Issue of ESRs under the
Employee Share Rights Plan to
incentivise selected employees to
grow the Company and to attract,
motivate and retain key
employees.
Total number of Financial Products of the Class after the
issue/acquisition/redemption/Conversion (excluding Treasury Stock)
and the total number of Financial Products of the Class held as
Treasury Stock after the issue/acquisition/redemption.
Total number of ESRs on issue as
at the date of this notice after the
issue disclosed in this notice:
886,792
1
The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.
In the case of an acquisition of shares, whether those shares are to
be held as treasury stock
Not applicable
Specific authority for the issue, acquisition, or redemption, including
a reference to the rule pursuant to which the issue, acquisition, or
redemption is made
Directors’ resolution dated 25
August 2026.
Terms or details of the issue, acquisition, or redemption (for
example: restrictions, escrow arrangements)
The ESRs will be issued on the
terms of the Employee Share
Rights Plan, the Sub-Plan for
France and the North America
Plan, as approved by the Board.
Date of issue/acquisition/redemption
2
8 September 2026
Section 3: Authority for this announcement and contact person
Name of person
authorised to make this announcement Raelene Leonard
Contact person for this announcement Raelene Leonard
Contact phone number +64 9 610 4803
Contact email address Raelene.Leonard@fphcare.co.nz
Date of release through MAP
9 September 2026
2
Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant issue/acquisition/redemptions were
made (for example, 1 January 2019 to 31 January 2019).
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- EBO — EBOS Group Limited: Capital Change Notice - Employee Share Plan2026-09-16
“Capital Change Notice Section 1: Issuer information Name of issuer EBOS Group Limited NZX ticker code EBO Class of financial product Ordinary Shares ISIN (If unknown, check on NZX website) NZEBOE0001S6 Currency NZD Section 2: Capital change details Number issued/acq…”
- GNE — Genesis Energy Limited: Capital Change Notice - Issue of Additional Share Rights2026-07-01
“Capital Change Notice • 3,307 RSRs have a vesting date of 30 June 2029). The balance of the principal conversion terms is set out in a Capital Change Notice lodged with NZX MAP on 1/08/2025. Reason for issue/acquisition/redemption and specific authority for issue/acq…”
- MCY — Mercury NZ Limited: Capital Change Notice2026-08-27
“Capital Change Notice Section 1: Issuer information Name of issuer Mercury NZ Limited (Mercury) NZX ticker code MCY Class of financial product Unquoted Performance Share Rights (PSRs), convertible to Mercury NZ Limited ordinary shares pursuant to Mercury NZ Limited – Sha…”